Tag Archives: Berkeley

The Ionocraft, Insect-sized Drone That Flies Without Any Moving Parts

Developed by researchers from the University of California, Berkeley, it’s not only described as the smallest flying robot ever made, but one which flies with zero moving parts: meaning no rotors, wings, or similar appendages. Instead, the insect-scale robot relies on atmospheric ion thrusters which allow it to move completely silently.


To understand how it works, imagine two asymmetric — [such as] a wire and a plate — electrodes,” said Daniel Drew, currently a Postdoctoral Fellow in the Mechanical Engineering department at Stanford University. “When a voltage is applied between the two, the electric field will be stronger in the vicinity of the wire as a function of its geometry. If this field is strong enough, an ambient electron can be pulled in with enough kinetic energy to initiate avalanche breakdown through impact ionization. There’s now a stable plasma, glowing purple in the dark, around the top wire. Generated ions will be ejected from this plasma, drifting in the electric field towards the bottom electrode. Along the way, they collide with neutral air molecules and impart momentum, producing a net thrust.”

Source: https://people.eecs.berkeley.edu/

Brain Metals Drive Alzheimer’s Progression

Alzheimer’s disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegenerative condition, by an international research collaboration including the University of Warwick.

Iron is an essential element in the brain, so it is critical to understand how its management is affected in Alzheimer’s disease. The advanced X-ray techniques that we used in this study have delivered a step-change in the level of information that we can obtain about iron chemistry in the amyloid plaques. We are excited to have these new insights into how amyloid plaque formation influences iron chemistry in the human brain, as our findings coincide with efforts by others to treat Alzheimer’s disease with iron-modifying drugs,” commented Dr Joanna Collingwood, from Warwick’s School of Engineering, who was part of a research team which characterised iron species associated with the formation of amyloid protein plaques in the human brainabnormal clusters of proteins in the brain. The formation of these plaques is associated with toxicity which causes cell and tissue death, leading to mental deterioration in Alzheimer’s patients.

They found that in brains affected by Alzheimer’s, several chemically-reduced iron species including a proliferation of a magnetic iron oxide called magnetite – which is not commonly found in the human brainoccur in the amyloid protein plaques. The team had previously shown that these minerals can form when iron and the amyloid protein interact with each other. Thanks to advanced measurement capabilities at synchrotron X-ray facilities in the UK and USA, including the Diamond Light Source I08 beamline in Oxfordshire, the team has now shown detailed evidence that these processes took place in the brains of individuals who had Alzheimer’s disease. They also made unique observations about the forms of calcium minerals present in the amyloid plaques.

The team, led by an EPSRC-funded collaboration between University of Warwick and Keele University – and which includes researchers from University of Florida and The University of Texas at San Antonio – made their discovery by extracting amyloid plaque cores from two deceased patients who had a formal diagnosis of Alzheimer’s. The researchers scanned the plaque cores using state-of-the-art X-ray microscopy at the Advanced Light Source in Berkeley, USA and at beamline I08 at the Diamond Light Source synchrotron in Oxfordshire, to determine the chemical properties of the minerals within them.

Source: https://warwick.ac.uk/